As shown in my Quality+Growth stock screener results in the table below, Merck meets all nineteen filters including scores in the 90s for both the overall Quality Score and the overall Growth Score filters.
A potential return-on-investment result is +1.0% absolute return-on-investment (equivalent to a +46.7% annualized
return-on-investment for the next 8 days) if the stock is assigned on the April 17th options expiration date.
The simultaneous buy/write transaction was as follows:
4/9/2025 Bought 200 shares of Merck & Co. stock @ $80.24 per share.
4/9/2025 Sold 2 MRK April 17th, 2025 $75.00 Call options @ $6.00 per share. The Implied Volatility of the Call options was 59.7 when this position was transacted.
Two possible overall performance results (including commissions) would be as follows:
Covered Calls Net Investment: $14,849.34
= ($80.24 - $6.00) * 200 shares + $1.34 commission Net Profit Components:
(a) Options Income: +$1,200.00
= ($6.00 * 200 shares)
(b) Dividend Income: +$0.00
(c) Capital Appreciation (If MRK shares assigned with stock above the $75.00 strike price at the April 17th options expiration date): -$1,048.00
= ($75.00 strike price - $80.24 stock purchase price) * 200 shares
Potential Net Profit (If MRK price is above $75.00 strike price at the 4/17/2025 options expiration): +$152.00
= (+$1,200.00 options income + $0.00 dividend income - $1,048.00 capital appreciation)
Potential Absolute Return-on-Investment: +1.0%
= +$152.00/$14,849.34
Potential Equivalent Annualized Return-on-Investment: +46.7%
= (+$152.00/$14,849.34) * (365/8 days)